Heartflow, Inc. Common Stock
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HTFL research report →
Companywww.heartflow.com
HeartFlow, Inc. , a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries.
- CEO
- John Farquhar
- IPO
- 2025
- Employees
- 626
- HQ
- Mountain View, CA, US
Price Chart
Valuation
- Market Cap
- $2.36B
- P/E
- -20.97
- P/S
- 12.34
- P/B
- 8.21
- EV/EBITDA
- -27.05
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 78.06%
- Op Margin
- -35.83%
- Net Margin
- -58.42%
- ROE
- 830.46%
- ROIC
- -21.94%
Growth & Income
- Revenue
- $176.03M · 39.92%
- Net Income
- $-116,791,000 · -21.12%
- EPS
- $-0.32 · 8.05%
- Op Income
- $-64,066,000
- FCF YoY
- 19.51%
Performance & Tape
- 52W High
- $41.22
- 52W Low
- $20.13
- 50D MA
- $27.56
- 200D MA
- $30.09
- Beta
- 1.99
- Avg Volume
- 1.32M
Get TickerSpark's AI analysis on HTFL
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 11, 26 | Farquhar John C.M. | sell | 22,562 |
| May 6, 26 | Jones Marie L. | other | 485 |
| May 7, 26 | Jones Marie L. | other | 82 |
| May 6, 26 | Rogers Campbell | other | 1,634 |
| May 7, 26 | Rogers Campbell | other | 637 |
| May 6, 26 | Verghese Vikram | other | 1,536 |
| May 7, 26 | Verghese Vikram | other | 473 |
| May 6, 26 | Farquhar John C.M. | other | 5,300 |
| May 7, 26 | Farquhar John C.M. | other | 1,904 |
| Apr 28, 26 | Bain Capital Life Sciences Investors, LLC | sell | 254,110 |
Our HTFL Coverage
We haven't published any research on HTFL yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate HTFL Report →